new post
StocksRunner logo
mail
search
 
menu
 
Crinetics Pharmaceut
$52.94
-0.88%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

CRNX Stock Analysis & IQ Rating | Crinetics Pharmaceuticals

 
 
 

CRNX

 

Crinetics Pharmaceuticals

$52.94

 
-$0.40 | -0.88%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$57.99
 
 
MKT CAP
$5.02B
 
52W Low
$24.1
 
 
VOL
$625.18K
 
P/E Ratio
N/A
 
 
AVG VOL
$1.32M
 
RSI
64.36
 
 
TREND
Uptrend
 
 
 

BQ Stock IQ

 
lock  Login to see Crinetics Pharmaceuticals (CRNX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

CRNX Target Price

 
 
 

Strengths

 
 

CRNX Rewards

 Upgraded on attractively valued

CRNX Rewards

 Outperform the market

 
 

CRNX Price Performance

 
 

$48.06   (+10.15%)

$44.43   (+19.15%)

$30.72   (+72.33%)

$30.72   (+72.33%)

 
 
1year
6month
3month
1month
 

CRNX Risk Level

 
 

CRNX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 
 
CRNX Risk Level
Low
LOW
HIGH
 

CRNX Analysts Opinion

 

CRNX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

CRNX Earnings Sentiment

 Loss widens YoY

 
 

Rating

×
 

Rating

 

CRNX Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

CRNX Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

CRNX Future Sentiment

 Outperform the market

 
 

CRNX Analysts Opinion

CRNX Analysts opinion is negative and it remained unchanged from the past 3 months

 

CRNX Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
83%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
80%
50%
100%
 

CRNX Street Sentiment 

CRNX Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

CRNX Performance Sentiment

 
Sentiments overview associated with CRNX events and the stock performance.
 
 
83%
8%
Positive
Negative
10 out of 12
events present
1 out of 12
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$45.95
 
Resistance
Price
 
$45.00
 
 
Current Price Range
 
$50.49
 
 
Show methods +
 
 
Linked to CRNX
IQ
Close Price
Change
 

GTBP

3.83

0.67

-9.09%

 
 
 
CRNX Latest Analysis +
 
 
FAQ About CRNX Stock Insights
 

What is CRNX current stock price?

What are CRNX stock strengths?

What is CRNX Risk Level?

What is CRNX market cap and volume?

What is CRNX current Stock IQ?

Should I buy CRNX stock right now?

Is CRNX a Strong Buy right now?

What does a 'Strong Buy' rating mean for CRNX?

What does a 'Strong Sell' rating mean for CRNX?

What factors influence CRNX's Stock IQ?

 
 
StocksRunner

Explore our CRNX Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored CRNX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our CRNX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 
 

CRNX

 

Crinetics Pharmaceuticals

 
 

Current Price

 

$52.94

 
-$0.40 | -0.88%
 
 
52W High
$57.99
 
 
MKT CAP
$5.02B
 
52W Low
$24.1
 
 
VOL
$625.18K
 
P/E Ratio
N/A
 
 
AVG VOL
$1.32M
 
RSI
64.36
 
 
TREND
Uptrend
 
 
 
Set Alerts
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

CRNX Rewards

 Upgraded on attractively valued

CRNX Rewards

 Outperform the market

 
 
 

Linked to CRNX

 
 
 
Symbol
IQ
Close
Change
 

GTBP

3.83

0.67

-9.09%

 
 
 
 
 
user
 
 
 
 

CRNX Price Performance

 
 

$48.06   (+10.15%)

$44.43   (+19.15%)

$30.72   (+72.33%)

$30.72   (+72.33%)

 
 
1year
6month
3month
1month
 

CRNX Analysts Opinion

 

CRNX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

CRNX Earnings Sentiment

 Loss widens YoY

 
 

Rating

×
 

Rating

 

CRNX Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

CRNX Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

CRNX Future Sentiment

 Outperform the market

 
 

CRNX Analysts Opinion

CRNX Analysts opinion is negative and it remained unchanged from the past 3 months

 

CRNX Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
83%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
80%
50%
100%
 

CRNX Street Sentiment 

CRNX Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

CRNX Risk Level

 
 

CRNX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 
 
CRNX Risk Level
Low
LOW
HIGH
 
CRNX Performance Sentiment
 
Sentiments overview associated with CRNX events and the stock performance.
 
 
83%
8%
Positive
Negative
10 out of 12
events present
1 out of 12
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$45.95
 
Resistance
Price
 
$45.00
 
 
Current Price Range
 
$50.49
 
 
Show methods +
 
 
 
 
 
 

CRNX Stock IQ

 
 
 
lock  Login to unlock Crinetics Pharmaceuticals (CRNX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

CRNX Latest Analysis

 
 
 

Crinetics plans $350 mln public share offering.

 

Mon Jan 5, 2026

$48.18 | +3.10%
 
Activity

Crinetics Pharmaceuticals announces $350M proposed public offering.

 

Mon Jan 5, 2026

$48.18 | +3.10%
 
Activity

Crinetics Pharmaceuticals Inc. (CRNX) Discusses PALSONIFY Launch Progress and Phase 2 Atumelnant Results in Congenital Adrenal Hyperplasia - Slideshow.

 

Mon Jan 5, 2026

$48.18 | +3.10%
 
Activity

Crinetics Pharmaceuticals Inc. (CRNX) Discusses PALSONIFY Launch Progress and Phase 2 Atumelnant Results in Congenital Adrenal Hyperplasia Transcript.

 

Mon Jan 5, 2026

$48.18 | +3.10%
 
Activity

Crinetics stock price target raised to $90 from $80 at Evercore ISI.

 

Mon Jan 5, 2026

$48.18 | +3.10%
 
Potential

Crinetics stock soars after strong PALSONIFY launch and positive trial data.

 

Mon Jan 5, 2026

$48.18 | +3.10%
 
Activity
Momentum

Crinetics To Provide Update On PALSONIFY And Topline Results From Phase 2 Trial Of Atumelnant In CAH . (RTTNews) - Crinetics Pharmaceuticals Inc. (CRNX) is scheduled to host a conference call to provide an update on its lead drug PALSONIFYs commercialisation and disclose topline results from the fourth cohort of its Phase 2 trial of Atumelnant in congenital adrenal hyperplasia o

 

Mon Jan 5, 2026

$48.18 | +3.10%
 
Activity

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines. Issued on behalf of GT Biopharma Inc. News Commentary – The oncology sector'.s pivot toward platform-based precision therapies has signaled smart money abandoning single-asset risk for companies engineering multiple drugs from validated mechanisms[1]. Antibody-drug conjugate pipelines expanding past 200 clinical candidates demonstrate how platform technologies enable rapid target-swapping while preserv

 

Fri Dec 19, 2025

$48.01 | +6.36%
 
Activity
Momentum
 
 
 
 
 
StocksRunner

Discover CRNX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of CRNX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our CRNX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CRNX Stock trends

CRNX Stock performance

CRNX Stock analysis

CRNX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

CRNX Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CRNX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CRNX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.